Development and Validation of a Novel Signature to Predict Overall Survival in "Driver Gene-negative" Lung Adenocarcinoma (LUAD): Results of a Multicenter Study.
Cui Y, Fang W, Li C, Tang K, Zhang J, Lei Y, He W, Peng S, Kuang M, Zhang H, Chen L, Xu D, Tang C, Zhang W, Zhu Y, Jiang W, Jiang N, Sun Y, Chen Y, Wang H, Lai Y, Li S, He Q, Zhou J, Zhang Y, Lin M, Chen H, Zhou C, Wang C, Wang J, Zou X, Wang L, Ke Z.
Cui Y, et al. Among authors: jiang n, jiang w.
Clin Cancer Res. 2019 Mar 1;25(5):1546-1556. doi: 10.1158/1078-0432.CCR-18-2545. Epub 2018 Nov 2.
Clin Cancer Res. 2019.
PMID: 30389658